ArticleAmerican journal of translational research2025
Effect of regorafenib combined with immunotherapy and arterial chemoembolization on the survival of patients with advanced hepatocellular carcinoma: a retrospective study.
Mingqiang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.